The Paul-Ehrlich-Institute (PEI) in Germany has granted approval to continue subject enrolment in cohort 5 of Oncolytics Biotech’s GOBLET trial, assessing pelareorep plus modified FOLFIRINOX in ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

GBR 1302, a bi-specific monoclonal antibody, is an artificial protein that is composed of fragments of two different monoclonal antibodies and consequently binds two different types of antigens ...

These therapies resulted from the research of Paul Ehrlich (Supplementary information ... Ehrlich was fortunate to have at his disposal an institute with top chemists and an institute equipped ...

Paul Ehrlich (1854-1915) was born in East Prussia (now Poland), the son of a lottery-office keeper. He went to the University of Leipzig to pursue a career in medicine. By the time he graduated in ...